Skip to main content

Table 1 Biochemical, imaging, clinical and diet therapy data of the patient

From: The biallelic novel pathogenic variants in AGL gene in a chinese patient with glycogen storage disease type III

  Before 8 days later 20 days later
Clinical data    
Age (years) 2 2 2
Height (cm) 85 85 85
Weight (kg)
Abdominal circumference(cm)
Right subcostal liver(cm)
14.2 14.2 14.2
59.5 60.0 59.0
10 10 10
Biochemical data    
Pre-prandial fasting blood glucose (mmol/L) 4.64 5.67 6.1
Nocturnal blood glucose(mmol/L) - 1.3 5.6
Morning fasting blood glucose (mmol/L) 2.5 4.1 6.5
Lactate (normal range 0.5–2.22mmol/L) 5.54 - -
Triglycerides (normal range 0–2.26 mmol/L) 5.45 3.71 2.4
Cholesterol (normal range 0–5.2 mmol/L) 5.50 4.96 5.05
Creatine kinase (normal range 40–200 U/L) 213 141 -
Aspartate transaminase (normal range 13–35 U/L) 1154.6 452 532
Alanine transaminase (normal range 7–40 U/L) 781.6 282 165
γ-glutamyl transpeptidase (normal range 7–45 U/L) 98 101 84
Troponin T (normal range 0–0.0223 ng/mL) 21.0 - -
Myoglobin (normal range 25–58 ng/mL) 0.01 - -
Imaging data    
Abdominal ultrasound Hepatomegaly - Hepatomegaly
Below umbilical level 55 mm
Abdominal computed tomography enhanced scan Hepatomegaly
No obvious abnormal enhancement
- -
Liver or muscle biopsy - - -
Electromyography normal - -
Electrocardiogram normal - -
Echocardiography normal - -
Chest computed tomography normal - -
Head computed tomography plain scan - - -
Skeletal system x-rays - - -
Diet therapy Regular diet Start uncooked cornstarch treatment 1-2 g/kg/d Adhere to uncooked cornstarch treatment 1-2 g/kg/d
  1. ‘-‘means no done